Brasada Capital Management LP Purchases 150 Shares of UnitedHealth Group Inc (NYSE:UNH)
Brasada Capital Management LP lifted its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 6.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,533 shares of the healthcare conglomerate’s stock after purchasing an additional 150 shares during the period. Brasada Capital Management LP’s holdings in UnitedHealth Group were worth $747,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently added to or reduced their stakes in UNH. Ashfield Capital Partners LLC increased its holdings in shares of UnitedHealth Group by 10.1% in the 1st quarter. Ashfield Capital Partners LLC now owns 69,551 shares of the healthcare conglomerate’s stock valued at $17,345,000 after acquiring an additional 6,395 shares during the last quarter. Bluefin Trading LLC lifted its holdings in shares of UnitedHealth Group by 503.4% in the 4th quarter. Bluefin Trading LLC now owns 36,464 shares of the healthcare conglomerate’s stock worth $10,720,000 after acquiring an additional 30,421 shares during the last quarter. Wishbone Management LP bought a new stake in shares of UnitedHealth Group in the 4th quarter worth about $51,447,000. MU Investments Co. Ltd. lifted its holdings in shares of UnitedHealth Group by 4.1% in the 1st quarter. MU Investments Co. Ltd. now owns 16,870 shares of the healthcare conglomerate’s stock worth $4,239,000 after acquiring an additional 670 shares during the last quarter. Finally, Dupont Capital Management Corp lifted its holdings in shares of UnitedHealth Group by 2.7% in the 1st quarter. Dupont Capital Management Corp now owns 89,381 shares of the healthcare conglomerate’s stock worth $22,290,000 after acquiring an additional 2,314 shares during the last quarter. 86.44% of the stock is owned by institutional investors.
In other news, Director Stephen J. Hemsley sold 45,637 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the sale, the director now directly owns 1,013,122 shares in the company, valued at approximately $292,903,701.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.80% of the stock is owned by company insiders.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.63 by $0.09. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The business had revenue of $64.40 billion for the quarter, compared to analyst estimates of $64.25 billion. During the same period in the prior year, the company posted $3.73 EPS. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, research analysts anticipate that UnitedHealth Group Inc will post 16.3 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, June 22nd were given a dividend of $1.25 per share. The ex-dividend date was Friday, June 19th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.08. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.62%. UnitedHealth Group’s dividend payout ratio (DPR) is 33.09%.
UNH has been the subject of several analyst reports. Stephens raised their target price on shares of UnitedHealth Group from $310.00 to $325.00 and gave the stock an “overweight” rating in a report on Tuesday, June 2nd. Deutsche Bank lowered their target price on shares of UnitedHealth Group from $308.00 to $293.00 and set a “buy” rating for the company in a report on Thursday, April 16th. SVB Leerink initiated coverage on shares of UnitedHealth Group in a report on Wednesday, July 1st. They set an “outperform” rating and a $360.00 price objective for the company. Jefferies Financial Group lifted their price objective on shares of UnitedHealth Group from $283.00 to $295.00 and gave the company a “hold” rating in a report on Friday. Finally, Royal Bank of Canada reiterated a “buy” rating and set a $341.00 price objective on shares of UnitedHealth Group in a report on Thursday, July 9th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and twenty-two have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average target price of $328.42.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Stochastic Momentum Index (SMI)
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.